SYRE vs TRMB · $7.60B cap vs P/E 26, rev $1.91B
Spyre Therapeutics Inc. (SYRE) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
Latest reported TRMB revenue for 2026-07-03 was $1.91B. Net income was -$372.8M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
SYRE currently screens at market cap $7.60B. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Not investment advice. Open the SYRE and TRMB stock pages for the full models.
Not investment advice.